Biotech

All Articles

Analysts go into Avidity's DMD win, disclosing nuances in records

.Avidity Biosciences satisfied entrepreneurs with phase 1/2 information in Duchenne muscular dystrop...

Actinogen's cortisol blocker neglects period 2 depression research

.Actinogen Medical's cortisol blocker has actually missed out on the major endpoint of a phase 2 stu...

Bivictrix decides going personal only method to take ADC into facility

.Antibody-drug conjugates (ADCs) have been at the facility of lots of a billion-dollar biobuck licen...

TPG tops up funds to $580M for expenditures around life sciences

.Property supervisor TPG, which has assisted biotechs like Sionna Therapeutics as well as Santa Ana ...

Merck stops phase 3 TIGIT test in bronchi cancer cells for impossibility

.Merck &amp Co.'s TIGIT system has experienced another trouble. Months after shuttering a phase 3 mo...

After a challenging year, Exscientia folds right into Recursion

.After a year determined by pipe cuts, the variation of its CEO and layoffs, Exscientia is going to ...

Cullinan, after $25M package, hands back bispecific to Port

.Cullinan Rehab was excited enough with Port BioMed's bispecific invulnerable reactor that it surren...

A closer take a look at Tough Biotech's Tough 15

.In this week's incident of "The Best Pipe," our company're diving in to Fierce Biotech's annual Fer...

Lilly encounters phase 2 breakdown of tau-targeting med

.The confetti is actually still soaring coming from Eli Lilly's gathering celebrating the commendati...

Biogen CMO Maha Radhakrishnan signs up with Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our roundup of substantial leadership hirings, shootings ...